Ultima-AOD9604 2mg-USA

Ultima-AOD9604, 2 mg

Ultima-AOD9604 2 mg contains AOD9604, a peptide fragment derived from the C-terminal region of human growth hormone. It has been researched primarily for fat metabolism, lipolysis, body-weight management, and body-composition pathways. Unlike full-length growth hormone, AOD9604 was investigated specifically for metabolic and fat-related effects without producing the same rise in IGF-1 seen with growth hormone.

How it works

AOD9604 is designed to reproduce the fat-metabolizing portion of growth hormone. Research has examined its ability to promote lipolysis, inhibit lipogenesis, and influence how adipose tissue handles stored fat.

Importantly, human studies found that AOD9604 did not significantly increase IGF-1 levels, distinguishing its investigated metabolic activity from full-length growth hormone.

Proper Use and Dosage

The listed product contains 2 mg (2,000 mcg) per vial.

Human clinical research has evaluated AOD9604 using several dosing ranges and administration routes. Oral studies investigated daily amounts from 0.25 mg to 54 mg, while a 24-week study evaluated 0.25 mg, 0.5 mg, and 1 mg daily.

For a 2 mg presentation:

• 250 mcg = 8 administrations
• 500 mcg = 4 administrations
• 1 mg = 2 administrations
• 2 mg = 1 full vial

The 0.25–1 mg daily range is particularly useful as a reference because these amounts were evaluated in a longer human study.

Benefits

Ultima-AOD9604 is particularly suited to research involving fat metabolism, body composition, and weight-management pathways.

Key benefits and areas of interest include:

• Supports lipolysis research
• Investigated for fat metabolism
• Supports research into inhibition of lipogenesis
• Relevant to body-composition research
• Investigated for abdominal and overall fat reduction
• Does not appear to increase IGF-1 in human studies
• Supports metabolic-health research
• Investigated as a growth-hormone-derived metabolic peptide
• Suitable for fat-loss-focused research
• Convenient 2 mg presentation

Its main appeal is its targeted metabolic profile, making AOD9604 particularly interesting for research focused on utilizing stored fat and improving body composition.

Side Effects

Human clinical studies reported generally good short-term tolerability, with commonly reported events including headache, gastrointestinal symptoms, diarrhea, nausea, fatigue, and dizziness. The overall adverse-event profile in the published trials was broadly similar to placebo.

Where to buy 

Whenever bodybuilders want to buy steroids online, it’s always expected that the steroids shop they buy from – Strength Labz, for example – has the products they desire. And luckily, Strength Labz has Ultima-AOD9604, 2 mg in stock.